BSE   25 May 12 | 03:50 PM 116.80 1.45 (1.26%) Mkt Price (Rs)   Chg Rs (Chg %) Code: 524804 Face Value: 1

NSE   25 May 12 | 12:00 AM 117.00 1.55 (1.34%) Mkt Price (Rs)   Chg Rs (Chg %) Code: AUROPHARMA

Performance 1 Week : Rs 108.05 (8.10%) 1 Month : Rs 127.35 (-8.28%) 1 Year : Rs 161.95 (-27.88%)

Smart Charts | Add to my portfolio | Derivative

News 24 May 12 14:28 Aurobindo Pharma surges 8% on US nod for anti-HIV drug 23 May 12 13:32 Aurobindo Pharma gets US nod for generic anti-HIV drug 16 May 12 14:11 Aurobindo gets USFDA approval for two tablets 04 Apr 12 00:24 Aurobindo Pharma, Hetero Drugs named in chargesheet against Jagan Reddy 02 Apr 12 09:47 Aurobindo Pharma under CBI scanner, stk plunges 8% 29 Mar 12 10:17 Aurobindo Pharma up on USFDA nod for generic Seroquel tabs

Stock Summary

Shareholding Pattern Promoters 54.76 % Mutual Funds / UTI 11.31 % FI/Bank 3.13 % Insurance 2.53 % Others 0.00 % Govt 0.00 % FII 12.42 % Non-Institutions 15.85 % Depository Receipts 0.00 % Total 100.00 %

Key Financials (Rs cr) Dec 2011 Dec 2010 YOY Operating Income 1,284.51 1,192.20 7.74 Total Expenses 1,093.35 880.38 24.19 Operating Profit 191.16 311.82 -38.70 Other Income 4.94 5.88 -15.99 PBDIT 196.10 317.70 -38.28 PBT -30.96 266.97 N.A Adjusted Net Profit -28.54 196.29 N.A

Peer Group Company Last (Rs) Chg (%) Mkt Cap (Rs cr) Strides Arcolab 674.85 -0.59 3,951 Pfizer 1,162.00 -0.12 3,468 Abbott India 1,474.70 2.20 3,134 Jubilant Life 179.10 0.39 2,853 Novartis India 737.15 2.49 2,356

Funds Owning this Stock Scheme Name Value (Rs cr) DSP BR Micro-Cap Fund (G) 8.39 Morgan Stanley Growth Fund (G) 9.66 Kotak 50 (G) 8.54 Kotak Opportunities (G) 6.89 UTI-Equity Fund (G) 0.00

Announcements

Research Reports Date Broker Action Price (Rs) Report 21/11 Angel Broking Buy 92 14/11 Anand Rathi Buy 120 10/08 Motilal Oswal Buy 308 10/08 Angel Broking Buy 158 10/05 Angel Broking Buy 194